[Efficacy and safety of neoadjuvant immunotherapy for hepatocellular carcinoma].
Xia YX, Zhang H, Zhang F, Li XC, Rong DW, Tang WW, Cao HS, Zhao J, Wang P, Pu LY, Qian XF, Cheng F, Wang K, Kong LB, Zhang CY, Li DH, Song JH, Yao AH, Wu XF, Wu C, Wang XH.
Xia YX, et al. Among authors: rong dw.
Zhonghua Wai Ke Za Zhi. 2022 Jul 1;60(7):688-694. doi: 10.3760/cma.j.cn112139-20220408-00150.
Zhonghua Wai Ke Za Zhi. 2022.
PMID: 35775262
Chinese.